Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Benitec Biopharma Ltd (OTC: BNIKF).

Full DD Report for BNIKF

Recent News from (OTC: BNIKF)

Benitec Biopharma's (BNIKF) CEO Greg West on Q2 2018 Results - Earnings Call Transcript
Benitec Biopharma Ltd. (BNIKF) Q2 2018 Results Conference Call February 22, 2018 05:00 PM ET Executives Greg West - CEO David Suhy - Chief Scientific Officer Georgina Kilfoil - Chief Development Officer Analysts Marc Sinatra - Lodge Partners Tim Boreham - Biotech Daily ...
Source: SeekingAlpha
Date: February, 26 2018 21:59
Benitec Biopharma (BTEBY) Presents At 10th Annual Biotech Showcase 2018 - Slideshow
The following slide deck was published by Benitec Biopharma Ltd ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: January, 09 2018 14:11
Benitec Biopharma's (BNIKF) CEO Greg West on Q2 2017 Results - Earnings Call Transcript
Benitec Biopharma Ltd. (BNIKF) Q2 2017 Earnings Conference Call August 29, 2017 6:00 PM ET Executives Greg West - Chief Executive Officer David Suhy - Chief Scientific Officer Georgina Kilfoil - Chief Clinical and Development Operations Officer Cliff Holloway - Chief Business a...
Source: SeekingAlpha
Date: August, 30 2017 00:22
Benitec Biopharma reports FY results
Benitec Biopharma ( OTCPK:BNIKF ): FY Net loss of A$5.7M Press Release More news on: Benitec Biopharma Ltd, Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: August, 29 2017 17:17
Benitec Biopharma's (BNIKF) CEO Greg West on Q1 2017 Results - Earnings Call Transcript
Start Time: 18:00 End Time: 18:35 Benitec Biopharma Ltd (BNIKF) Q1 2017 Earnings Conference Call May 30, 2017, 18:00 PM ET Executives Greg West - CEO David Suhy - CSO Cliff Holloway - Chief Business and Operations Officer Georgina Kilfoil - Chief Clinical and Development Op...
Source: SeekingAlpha
Date: May, 30 2017 23:07
Benitec Biopharma's (BNIKF) CEO Greg West on Q4 2016 Results - Earnings Call Transcript
Benitec Biopharma Ltd (BNIKF) Q4 2016 Earnings Conference Call August 30, 2016 06:00 PM ET Executives Sakura Holloway - SVP Corporate Operations & IP Counsel Greg West - CEO Peter Francis - Chairman David Suhy - CSO Cliff Holloway - Chief Business and Operations Officer ...
Source: SeekingAlpha
Date: August, 30 2016 22:56
Benitec Biopharma's (BNIKF) Interim CEO Greg West on Q3 2015 Results - Earnings Call Transcript
Benitec Biopharma Ltd (BNIKF) Q4 2015 Earnings Conference Call May 24, 2016 18:00 PM ET Executives Greg West - Interim Chief Executive Officer Peter Francis - Chairman David Suhy - Chief Scientific Officer Georgina Kilfoil - Chief Clinical and Development Operations Officer C...
Source: SeekingAlpha
Date: May, 25 2016 01:34
Week In Review: WuXi's SynTheAll Subsidiary Raises $80 Million
Deals and Financings Read more »
Source: SeekingAlpha
Date: July, 12 2015 08:43
Benitec And Bluebird Bio, Gene Therapy Coming Of Age?
Gene therapy has lived through lots of false horizons. The goal of this approach to treating genetic disease or infection has been to prevent manufacture of defective proteins or proteins that are key to infection in hard to treat (e.g. viral) diseases. It has also been realised that in many...
Source: SeekingAlpha
Date: July, 06 2015 12:24
Biotech Investors Should Read Bibliographies Of Chief Scientific Officers
Publication of peer-reviewed, original research is how investigators in medical science prove themselves. Yet short-sighted investors focus on presentations at meetings, and not on science published in prestigious journals after world class peer review. Authors writing for Seeking Alpha focus ...
Source: SeekingAlpha
Date: June, 30 2015 12:42

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-260.1450.1450.1450.1455,000
2018-04-25N/A0.145N/AN/A0
2018-04-240.1450.1450.1450.1459,500
2018-04-23N/A0.152N/AN/A0
2018-04-22N/A0.152N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-1625,00061,00040.9836Short
2018-03-23200200100.0000Short
2018-02-2830,00037,66579.6495Short
2018-02-06424424100.0000Short
2018-01-184,7005,20090.3846Short

* Short Mode

Short Analysis provided by Squeeze Report.


About Benitec Biopharma Ltd (OTC: BNIKF)

Logo for Benitec Biopharma Ltd (OTC: BNIKF)

Not available

 

Contact Information

 

 

Current Management

  • Peter French / CEO, Managing Director
  • Greg West / Secretary

Current Share Structure

     


    Recent Filings from (OTC: BNIKF)

    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 24 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: February, 22 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: February, 22 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: January, 30 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: January, 23 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: January, 17 2018
    Notice from the SEC of registration effectiveness
    Filing Type: EFFECTFiling Source: edgar
    Filing Date: December, 11 2017
    Post-effective amendment to an S-Type filing
    Filing Type: POS AMFiling Source: edgar
    Filing Date: December, 08 2017
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: November, 29 2017
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: November, 29 2017

     

     


    Daily Technical Chart for (OTC: BNIKF)

    Daily Technical Chart for (OTC: BNIKF)


    Stay tuned for daily updates and more on (OTC: BNIKF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: BNIKF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    The Subway Trader
    @TheSubwayTrader

     

     


    Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BNIKF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of BNIKF and does not buy, sell, or trade any shares of BNIKF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/

     

     

    Release this Report to Investors

    Via Email

    Via Text

    Important

    If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us